They also indicated that glioblastoma cells that did not respond to temozolomide chemotherapy had lower mRNA expression levels of NFKBIA, and that the increased expression of NFKBIA inhibited the malignant behavior of the tumor. This evidence concerns the gene NFKBIA and neoplasm.